BrainJuicer Group plc beats forecasts, but is it a better buy than Next Fifteen Communications plc?

Both these marketing firms could grow alongside quality client lists including Heineken, Shell, Apple and Microsoft. But which, if any, should you buy?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

This morning BrainJuicer plc (LSE: BJU), the unorthodox marketing firm, upgraded full-year profit forecasts on the back of strong performances from its Advertising Testing and Brand Tracking services. The company boasts an impressive client portfolio, including Heineken, Hershey’s and Shell.

Another extraordinary marketing firm, Next Fifteen Communications (LSE: NFC), has an equally impressive customer base including Alphabet, Apple and Microsoft.

Many investors believe these two companies could grow alongside their clients, but is BrainJuicer the better buy after today’s positive update, or does Next Fifteen’s consistent track record give it the edge?

BrainJuicer doesn’t believe in persuading customers using facts and figures. Humans tend to make snap decisions and consider only the top three or four brands when buying low-ticket items like ice creams.

Therefore, rather than focusing on the logical qualities of a product BrainJuicer bases its campaigns around “Fame, Feeling and Fluency.”

This novel approach drove an incredible 30% compound annual revenue growth rate between 2005 and 2013, with profits following along. The company’s expansion has been more muted in recent years however, growing only 3% total since then.

Its share price is approaching all-time highs, which seems overdone considering recent lacklustre revenue growth. Management also failed to quantify the outperformance, therefore lowering its value.

Today’s news is great for current shareholders, but a PE of 20 times might seem a little steep for those looking to buy the shares, especially if BrainJuicer can’t reignite revenue growth.

Two decades of growth

Next Fifteen Communications provides tech giants with PR, marketing and niche technical services.

The company might not have expanded as quickly as BrainJuicer, but its track record is no less impressive given its consistency. It has been profitable in all but two of the last 20 years and has grown revenue from £7.9m to £129.8m, or a CAGR of 6.9% in the same period.

A slew of acquisitions has turned it into a full-service provider over the last few years, which could facilitate revenue growth for some time.

BrainJuicer’s revenue growth has slowed down a little over the last few years, but Next Fifteen’s has been picking up the pace, jumping 23% last year.

I believe Next Fifteen’s revenues could be more defensible than BrainJuicer’s too because serving companies like Apple requires a deep understanding of tech that isn’t easily replicated.

BrainJuicer or Next15?

BrainJuicer has used its pause in growth to focus on margin expansion. The company reported an impressive 19% operating margin last year, compared to Next Fifteen’s 8%. Such a high figure implies that its services are still unique, otherwise competition would likely drag down profitability towards single-digits.

Next Fifteen trades at a rich 60 times last year’s earnings, but this figure doesn’t take into account the company’s rapid expansion, or its strong cash-flow. You see, earnings have recently been hit by high amortisation costs following past acquisitions. If we ignore these non-cash charges, the company looks a little cheaper at only 23 times free cash flow generated in the last 12 months.

Interestingly, BrainJuicer trades on 22 times the same metric. 

Both these companies are worth a closer look, in my view, but I believe Next Fifteen’s recent momentum make it a more attractive proposition than BrainJuicer’s, in spite of today’s upgrade.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Zach Coffell has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

£3,000 in savings? Here’s how I’d use that to start earning a monthly passive income

Our writer digs into the details of how spending a few thousand pounds on dividend shares now could help him…

Read more »

Investing Articles

Here’s what dividend forecasts could do for the BP share price in the next three years

I can understand why the BP share price is low, as oil's increasingly seen as evil. But BP's a cash…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

This FTSE 100 Dividend Aristocrat is on sale now

Stephen Wright thinks Croda International’s impressive dividend record means it could be the best FTSE 100 stock to add to…

Read more »

Investing Articles

3 shares I’d buy for passive income if I was retiring early

Roland Head profiles three FTSE 350 dividend shares he’d like to buy for their passive income to support an early…

Read more »

Investing Articles

Here’s how many Aviva shares I’d need for £1,000 a year in passive income

Our writer has been buying shares of this FTSE 100 insurer, but how many would he need to aim for…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

1 incredible growth stock I can’t find on the FTSE 100

The FTSE 100 offers us a lot of interesting investment opportunities, but there's not much in the way of traditional…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

With an £8K lump sum, I could create an annual second income worth £5,347

This Fool explains how a second income is achievable by using a lump sum, investing in stocks, and the magic…

Read more »

Investing Articles

Here’s what dividend forecasts could do for the BT share price in the next 3 years

With the BT share price down so low, the dividend looks very nice indeed. The company's debt is off-putting, though.…

Read more »